Free Trial

Chromocell Therapeutics (CHRO) SEC Filings & 10K Form

Chromocell Therapeutics logo
$1.68 +0.05 (+3.07%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$1.72 +0.04 (+2.32%)
As of 02/21/2025 04:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Chromocell Therapeutics SEC Filings

DateFilerForm TypeView
02/14/2025
12:09 PM
Chromocell Therapeutics (Subject)
Ikarian Capital, LLC (Filed by)
Form SCHEDULE 13G
01/15/2025
4:27 PM
Alexandra Wood Inc. (0002052171) (Filed by)
Chromocell Therapeutics (Subject)
Form SCHEDULE 13G
12/19/2024
11:15 PM
Chromocell Therapeutics (Filer)
Form EFFECT
12/11/2024
3:06 PM
Chromocell Therapeutics (Filer)
Form POS AM
12/02/2024
11:15 PM
Chromocell Therapeutics (Filer)
Form EFFECT
11/22/2024
3:30 PM
Chromocell Therapeutics (Filer)
Form POS AM
11/21/2024
8:00 AM
Chromocell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
4:03 PM
Chromocell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2024
3:19 PM
Chromocell Therapeutics (Issuer)
Friedberg Ezra M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2024
3:20 PM
Chromocell Therapeutics (Issuer)
Malamut Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2024
3:22 PM
Chromocell Therapeutics (Issuer)
Davis Todd C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
4:19 PM
Chromocell Therapeutics (Filer)
Form 424B3
11/13/2024
4:14 PM
Chromocell Therapeutics (Filer)
Form 424B3
11/13/2024
3:30 PM
Chromocell Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2024
3:05 PM
3i, LP (Filed by)
Chromocell Therapeutics (Subject)
Form SC 13G/A
10/24/2024
7:30 AM
Chromocell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2024
4:08 PM
Chromocell Therapeutics (Filer)
Form DEF 14A
09/16/2024
3:55 PM
Chromocell Therapeutics (Issuer)
Francis Knuettel II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
3:56 PM
Chromocell Therapeutics (Issuer)
Malamut Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
4:35 PM
Chromocell Therapeutics (Issuer)
Francis Knuettel II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
4:30 PM
Chromocell Therapeutics (Filer)
Form PRE 14A
08/13/2024
4:23 PM
Chromocell Therapeutics (Filer)
Form 424B3
08/13/2024
4:19 PM
Chromocell Therapeutics (Filer)
Form 424B3
08/13/2024
3:31 PM
Chromocell Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2024
3:50 PM
Chromocell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
11:15 PM
Chromocell Therapeutics (Filer)
Form EFFECT
08/06/2024
3:49 PM
Chromocell Therapeutics (Filer)
Form 424B3
07/29/2024
8:06 AM
Chromocell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/29/2024
8:07 AM
Chromocell Therapeutics (Filer)
Form 424B3
07/29/2024
8:08 AM
Chromocell Therapeutics (Filer)
Form 424B3
07/29/2024
8:15 AM
Chromocell Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
07/02/2024
4:15 PM
Chromocell Therapeutics (Issuer)
Francis Knuettel II (Reporting)
Form 3/A
07/02/2024
4:17 PM
Chromocell Therapeutics (Issuer)
Francis Knuettel II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
7:05 PM
Chromocell Therapeutics (Issuer)
Lang Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
7:06 PM
Chromocell Therapeutics (Issuer)
Simmons Chia-Lin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
7:07 PM
Chromocell Therapeutics (Issuer)
Francis Knuettel II (Reporting)
Form 4/A
06/18/2024
7:00 PM
Chromocell Therapeutics (Issuer)
Davis Todd C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
7:01 PM
Chromocell Therapeutics (Issuer)
Francis Knuettel II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
7:02 PM
Chromocell Therapeutics (Issuer)
Malamut Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
7:03 PM
Chromocell Therapeutics (Issuer)
Friedberg Ezra M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
3:21 PM
Chromocell Therapeutics (Filer)
Form 424B3
The FED is losing the war on inflation (Ad)

It's no longer just a “guesstimate” – Inflation is indeed getting worse. And although we want to believe the Fed has a good grip on it, they don't. Right now, the suits over there are caught between a rock and a hard place. Either they watch as inflation grows, or they tear it down and send us into a full-blown recession. The kicker here is that neither of these are good for you. Whichever pill we end up with, prices will still climb higher as the value of the dollar sinks lower. The only real way out for the regular person is to increase your earning power. By increasing your income to match prices as they flare up… You’ll stay ahead of the impending doom we're running face-first into. And if you're looking for a strategy to help increase your income in 2025… I've got just the thing for you! You see, last year, I was able to grow a $10k model account to a little over $63k with 100 trade alerts But I changed my trading rules and more than doubled my results on those 100 published trades. I'm now calling them Warped Options…

You can go here to give yourself a head start.
05/15/2024
3:15 PM
Chromocell Therapeutics (Filer)
Form 424B3
04/16/2024
3:48 PM
Chromocell Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/12/2024
6:22 PM
Chromocell Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
04/09/2024
7:30 AM
Chromocell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2024
8:00 AM
Chromocell Therapeutics (Filer)
Form NT 10-K
03/21/2024
8:00 AM
Chromocell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2024
7:00 AM
Chromocell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/01/2024
4:10 PM
Chromocell Therapeutics (Subject)
Motif Pharmaceuticals Ltd. (Filed by)
Form SC 13G
03/01/2024
4:13 PM
AME Equities LLC (Filed by)
Chromocell Therapeutics (Subject)
Form SC 13G
03/01/2024
4:16 PM
Aperture Healthcare Ventures Ltd. (Filed by)
Chromocell Therapeutics (Subject)
Form SC 13G
03/01/2024
4:19 PM
Benuvia Operations, LLC (Filed by)
Chromocell Therapeutics (Subject)
Form SC 13G
02/26/2024
5:36 PM
Chromocell Therapeutics (Subject)
Friedberg Ezra M (Filed by)
Form SC 13D
02/23/2024
4:12 PM
Chromocell Therapeutics (Issuer)
Friedberg Ezra M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
4:15 PM
Chromocell Therapeutics (Issuer)
Davis Todd C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
4:17 PM
Chromocell Therapeutics (Issuer)
Francis Knuettel II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:CHRO) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners